Pharmaids Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	1,138	976	2,422	1,834	489	129
Market Cap Growth	-48.14%	-59.71%	32.06%	275.20%	278.93%	11.90%
Enterprise Value	1,370	1,169	2,515	1,825	494	128
Last Close Price	32.28	27.67	68.67	52.00	21.81	12.51
PE Ratio	-	-	-	-	-	88.87
PS Ratio	4.08	3.50	12.41	11.99	-	3.28
PB Ratio	2.39	2.05	4.40	2.60	2.18	1.49
P/TBV Ratio	7.01	6.01	8.85	4.58	2.18	1.49
EV/Sales Ratio	4.92	4.19	12.89	11.93	-	3.25
EV/EBITDA Ratio	-	-	-	-	-	94.04
EV/EBIT Ratio	-	-	-	-	-	100.22
Debt / Equity Ratio	0.49	0.49	0.71	0.12	-	-
Net Debt / Equity Ratio	0.49	0.49	0.67	0.05	-0.71	-0.05
Net Debt / EBITDA Ratio	-1.72	-1.72	-2.88	-0.31	1.62	-2.99
Net Debt / FCF Ratio	-2.73	-2.73	-1.39	-0.11	2.82	1.57
Asset Turnover	0.27	0.27	0.19	0.26	-	0.39
Inventory Turnover	2.72	2.72	1.68	-	-	5.68
Quick Ratio	0.15	0.15	0.18	0.65	8.53	0.72
Current Ratio	0.46	0.46	0.78	1.17	8.62	1.09
Return on Equity (ROE)	-22.55%	-22.55%	-21.52%	-25.48%	-48.54%	1.69%
Return on Assets (ROA)	-9.39%	-9.39%	-8.94%	-14.92%	-34.69%	0.79%
Return on Capital Employed (ROCE)	-24.60%	-24.60%	-16.60%	-17.30%	-44.10%	1.50%
Earnings Yield	-10.29%	-12.01%	-4.45%	-4.35%	-15.46%	1.13%
FCF Yield	-7.49%	-8.74%	-10.93%	-18.26%	-11.65%	-2.01%
Buyback Yield / Dilution	-0.37%	-0.37%	-55.24%	-76.16%	-25.07%	-